Cargando…
Macrophage CD5L is a target for cancer immunotherapy
BACKGROUND: Reprogramming of immunosuppressive tumor-associated macrophages (TAMs) presents an attractive therapeutic strategy in cancer. The aim of this study was to explore the role of macrophage CD5L protein in TAM activity and assess its potential as a therapeutic target. METHODS: Monoclonal ant...
Autores principales: | Sanchez-Moral, Lidia, Paul, Tony, Martori, Clara, Font-Díaz, Joan, Sanjurjo, Lucía, Aran, Gemma, Téllez, Érica, Blanco, Julià, Carrillo, Jorge, Ito, Masaoki, Tuttolomondo, Martina, Ditzel, Henrik J., Fumagalli, Caterina, Tapia, Gustavo, Sidorova, Julia, Masnou, Helena, Fernández-Sanmartín, Marco-Antonio, Lozano, Juan-José, Vilaplana, Cristina, Rodriguez-Cortés, Alhelí, Armengol, Carolina, Valledor, Annabel F., Kremer, Leonor, Sarrias, Maria-Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139961/ https://www.ncbi.nlm.nih.gov/pubmed/37054630 http://dx.doi.org/10.1016/j.ebiom.2023.104555 |
Ejemplares similares
-
CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content
por: Bárcena, Cristina, et al.
Publicado: (2019) -
CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3
por: Sanjurjo, Lucía, et al.
Publicado: (2018) -
Multifaceted Roles of CD5L in Infectious and Sterile Inflammation
por: Sanchez-Moral, Lidia, et al.
Publicado: (2021) -
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
por: Martori, Clara, et al.
Publicado: (2022) -
The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses
por: Sanjurjo, Lucía, et al.
Publicado: (2015)